Who owns Neurocrine Biosciences?

Key details on Neurocrine Biosciences (Ticker: NBIX)

Who owns Neurocrine Biosciences?

Is NBIX a good stock to own? Find out who bought Neurocrine Biosciences, who sold Neurocrine Biosciences (NBIX) stock, and who holds a large position in Neurocrine Biosciences.

Fund Name Number of Shares Share Valuation As Of
FMR 11.30M $181.91M March 31, 2014
T. Rowe Price Associates 10.26M $165.14M March 31, 2014
BVF 5.93M $50.40M Dec. 31, 2011
OrbiMed Advisors 5.45M $87.76M March 31, 2014
Perceptive Advisors 4.62M $74.37M March 31, 2014
BB Biotech AG 3.00M $48.24M March 31, 2014
BlackRock Fund Advisors 2.81M $45.22M March 31, 2014
STATE STREET CORPORATION 2.24M $36.14M March 31, 2014
Vanguard 2.22M $35.76M March 31, 2014
Franklin Resources 2.20M $35.49M March 31, 2014
BlackRock Institutional Trust Company, N.A. 2.08M $33.55M March 31, 2014
Visium Asset Management 2.00M $32.22M March 31, 2014
S.A.C. Capital Advisors 1.88M $14.07M Dec. 31, 2012
Jennison Associates 1.64M $18.59M Sept. 30, 2013
Hambrecht & Quist Capital Management 1.48M $11.09M Dec. 31, 2012
Turner Investments 1.27M $14.39M Sept. 30, 2013
VHCP Management 1.27M $14.39M Sept. 30, 2013
Arrowpoint Asset Management 1.26M $20.23M March 31, 2014
RA Capital Management 1.17M $18.82M March 31, 2014
PointState Capital 1.12M $15.05M June 30, 2013
Loomis, Sayles and 1.12M $14.99M June 30, 2013
BlackRock Advisors 1.06M $17.13M March 31, 2014
Deutsche Bank Aktiengesellschaft 1.06M $9.68M Dec. 31, 2013
Wellington Management Company 1.05M $8.31M June 30, 2012
Meditor 1.05M $11.89M Sept. 30, 2013